See What You Feel
The Eclipse Device
The Eclipse incorporates a number of innovative technologies into its design providing users with the ability to see, feel, map and decipher cancerous and pre-cancerous tumors deep within the breast tissue. The technology behind the Eclipse device provides a level of confidence and accuracy in detection that was previously unattainable.
The technology works similarly to the tactile breast exam performed by an individual or doctor, but collects data using a proprietary, image-based sensor. The device is capable of detecting an occult mass as small as 5mm, up to 35mm beneath a compressed surface with an incremental resolution under 1mm.
Simply put, our sensor technology allows women to detect breast abnormalities earlier, in the comfort of their own home with a non-invasive and radiation-free hand-held device.
Only the beginning
The Eclipse device is the main component of a much larger ecosystem in which users will be able to seamlessly interact with their physician through our HIPAA compliant, cloud-based smartphone application and a personalized risk profile, providing users with individually tailored best-practices for total breast health.
Eclipse FDA Registration # ECL6198
Eclipse is now engaged in its commercial phase and is currently working with the FDA to finalize its technology and regulatory requirements.
- The Eclipse device is not intended to diagnose, treat, cure or prevent any disease.
- The FDA has not yet fully evaluated the Eclipse device, technology, services or statements.
- The Eclipse is designed to be an adjunct tool for medical industry standards, and is not designed to replace mammography or any gold standard practices.
- The attached videos and their content are intended to give a glimpse of Eclipse’s vision and future and are not intended to imply that Eclipse is currently available on the market at this time.